Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

American Cancer Society’s VC arm partners with Third Rock on oncology companies

  • Allison DeAngelis

By Allison DeAngelis July 26, 2022

Reprints
opioid settlement
Adobe

Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention for the last decade.

But the American Cancer Society sees gaps.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Allison DeAngelis

Allison DeAngelis

Biotech Startups and Venture Capital Reporter

Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital.

Tags

Create a display name to comment

This name will appear with your comment

Your questions on the new Covid vaccine boosters answered
Your questions on the new Covid vaccine boosters answered
A Q&A with WHO’s Maria Van Kerkhove on Covid…
A Q&A with WHO’s Maria Van Kerkhove on Covid — and fatigue over the pandemic
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Pharmalittle: Illumina faces more challenges after winning FTC case;…
Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics
People with terminal cancer need to know they are…
People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information
Illumina wins case against FTC in bid to hold…
Illumina wins case against FTC in bid to hold onto early cancer detection company Grail

Recommended Stories